<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0010783'>Erythema</z:hpo> infectiosum (<z:e sem="disease" ids="C0085273" disease_type="Disease or Syndrome" abbrv="">fifth Disease</z:e>) is the major clinical manifestation of human parvovirus B19 (HPV B19) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>HPV B19 is known to be associated with adverse effects on fetuses such as <z:hpo ids='HP_0001789'>hydrops fetalis</z:hpo>, <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, intrauterine fetal <z:hpo ids='HP_0011420'>death</z:hpo>, and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001903'>anemia</z:hpo> in immunocompromised individuals </plain></SENT>
<SENT sid="2" pm="."><plain>The objective of this study was to assess seroprevalence to HPV B19 in three different groups in Shiraz, Iran </plain></SENT>
<SENT sid="3" pm="."><plain>The first group included 91 to-be-married girls </plain></SENT>
<SENT sid="4" pm="."><plain>The second group included 184 pregnant women and the third group consisted of 184 neonates, who were born to the women in the second group </plain></SENT>
<SENT sid="5" pm="."><plain>Specific IgG and IgM antibodies to HPV B19 were measured using ELISA technique </plain></SENT>
<SENT sid="6" pm="."><plain>Results showed that the prevalence for IgG to HPV B19 was 56 (61.5%), 127 (69%), and 127 (69%) for the first, second, and third groups, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Overall, 183 out of the 275 (66.5%) women of childbearing age had IgG to HPV B19 </plain></SENT>
<SENT sid="8" pm="."><plain>The seroprevalence for IgM to HPV B19 was 2.2% for the second group </plain></SENT>
<SENT sid="9" pm="."><plain>There was no detectable IgM in umbilical cord sera or in the first group blood samples </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, approximately one-third of individuals in the study who were of childbearing age were at risk for primary HPV B19 <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
</text></document>